Reblozyl Patient Assistance Program

Key Takeaways

  1. Reblozyl (luspatercept-aamt) is a prescription erythroid maturation agent used to treat certain types of anemia in adults. It promotes the maturation of red blood cells and may help improve anemia or reduce the need for red blood cell transfusions in eligible patients.
  2. Reblozyl is approved for specific forms of anemia associated with beta thalassemia and certain lower-risk myelodysplastic syndromes (MDS). It is not indicated as a substitute for red blood cell transfusions when immediate correction of anemia is required.
  3. As a specialty biologic medication administered by subcutaneous injection, Reblozyl may involve significant treatment costs. Prescription Hope helps eligible patients explore patient assistance programs and potential options for more affordable access to prescription medications.

 

Introduction

Certain blood disorders can interfere with the body’s ability to produce mature red blood cells and lead to anemia. Reblozyl is a prescription biologic medication designed to promote red blood cell maturation in certain adults with beta thalassemia or specific myelodysplastic disorders.

Depending on the condition being treated, this medication may help improve anemia and reduce the need for red blood cell transfusions. It is administered by subcutaneous injection once every three weeks, with dosing adjustments based on the condition being treated, hemoglobin levels, and transfusion requirements.

Because specialty biologic medications can involve significant treatment costs, affordability may be a concern for some patients. Prescription Hope helps eligible patients navigate medication assistance programs and explore potential options for more affordable access to prescribed medications.

What Is the Reblozyl Patient Assistance Program?

Understanding Reblozyl Prescription Assistance

With the high cost of specialty medications, many patients search for affordable options, savings programs, or patient assistance programs that can help reduce out-of-pocket expenses.

Manufacturers recognize that patients prescribed treatments such as luspatercept-aamt, marketed as Reblozyl, may need financial relief, which is why many offer assistance programs for qualified patients seeking anemia medication assistance, prescription assistance, or Reblozyl financial assistance.

These programs can make medications more affordable for qualified patients, including those looking for luspatercept-aamt assistance or medication financial assistance. However, the application process can be difficult to navigate, often leaving patients frustrated when trying to apply on their own.

How Expert Advocates Help Make Reblozyl More Affordable

Personalized Medication Assistance

Patients seeking trusted prescription assistance specialists can turn to Prescription Hope for support with luspatercept-aamt assistance, anemia medication assistance, and prescription assistance. Our patient support services help manage the patient assistance program application process from start to finish.

Our dedicated team handles form completion, document and signature collection, coordination with healthcare providers and manufacturers, and the many administrative details involved in patient assistance programs.

Ongoing Patient Support

At Prescription Hope, our support does not stop with application services. We also provide long-term medication access support, including Reblozyl patient support, prescription support, and anemia treatment support. Our team manages the administrative details involved in patient assistance programs, including form and document updates, issue resolution, program monitoring, yearly renewals, and refill scheduling.

Reblozyl Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$4,187.93

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Treatment Costs

Specialty medications can be extremely expensive, but cost assistance through Prescription Hope may help make treatment more manageable for qualified patients searching for medication affordability.

For $70.00 per month, per medication, qualified patients can access medication assistance without hidden charges or fees, variable pricing systems, or additional medication costs—offering support for those who need help paying for Reblozyl.

Reblozyl Patient Assistance Eligibility

General Eligibility Requirements

While the best way to determine specific Reblozyl patient assistance eligibility is to enroll with Prescription Hope, it can be helpful to understand the general requirements that may apply to Reblozyl assistance eligibility, Reblozyl financial assistance eligibility, and Reblozyl prescription assistance eligibility.

General requirements may include:

Income: Each program maintains its own income guidelines or income threshold.

Insurance: Each program may have its own requirements regarding insurance coverage status.

Prescription: Qualified patients must have a valid prescription for the name-brand medication they wish to apply for.

U.S. Residency: Qualified patients must have legal U.S. residency.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Ready to apply for Reblozyl assistance? Prescription Hope enrollment makes the process simple. Our team helps qualified patients with Reblozyl patient assistance enrollment and guides them through the Reblozyl assistance application in six simple steps:

  1. Submit Information: Complete our online form in just a few minutes from the comfort of your home.
  2. Advocate Contact: A patient advocate will contact you within 1-2 business days to discuss your Reblozyl prescription assistance options.
  3. Document Collection: After a quick prequalification, our team will collect the documents needed for your Reblozyl assistance application.
  4. Provider Coordination: Our team works with your healthcare provider to secure required signatures and help move your application forward.
  5. Program Submission: Our team completes your application packet, submits it, and continues to follow up with the manufacturer on your behalf.
  6. Medication Delivery: Once approved, qualified patients can typically expect to receive their medication within two weeks, though shipping times may vary. Medication shipments arrive directly from the manufacturer to your home or doctor’s office.

Understanding Reblozyl

How Reblozyl Works

Reblozyl is an erythroid maturation agent designed to promote the maturation of red blood cells.

It binds certain naturally occurring proteins in the transforming growth factor-beta (TGF-β) superfamily, reducing Smad2/3 signaling. This helps promote late-stage red blood cell maturation and erythropoiesis.

In simple terms, this medication helps the body produce more mature red blood cells in certain conditions associated with ineffective red blood cell production.

What Conditions Does Reblozyl Treat?

Reblozyl is FDA-approved to treat anemia in adults with:

  • Beta thalassemia who require regular red blood cell transfusions
  • Very low- to intermediate-risk MDS who are ESA-naïve and may require regular RBC transfusions
  • Very low- to intermediate-risk MDS with ring sideroblasts (MDS-RS) or MDS/MPN-RS-T whose anemia has failed ESA treatment and who require 2 or more RBC units over 8 weeks

This medication is not indicated as a substitute for red blood cell transfusions when immediate correction of anemia is required.

Benefits of Treatment

Depending on the condition being treated, this medication may:

  • Help improve anemia
  • Reduce the need for red blood cell transfusions
  • Promote red blood cell production
  • Provide treatment for certain patients with beta thalassemia or lower-risk MDS

Important Safety Information and Side Effects

Reblozyl does not carry an FDA Boxed Warning.

Thrombosis and Thromboembolism

This medication can increase the risk of blood clots, particularly in patients with beta thalassemia.

Reported thromboembolic events have included:

  • Deep vein thrombosis
  • Pulmonary embolism
  • Portal vein thrombosis
  • Ischemic stroke

Hypertension

Reblozyl can cause or worsen high blood pressure. Blood pressure should be monitored before treatment and during therapy.

Extramedullary Hematopoietic Masses

Reblozyl may cause or worsen extramedullary hematopoietic (EMH) masses, particularly in patients with beta thalassemia. Patients should be monitored for symptoms or complications related to EMH masses.

Common Side Effects

Common adverse reactions may include:

  • Fatigue
  • Headache
  • Musculoskeletal or joint pain
  • Dizziness or vertigo
  • Nausea
  • Diarrhea
  • Cough
  • Abdominal pain
  • Shortness of breath
  • Swelling of the hands, legs, or feet
  • High blood pressure
  • Hypersensitivity reactions

The specific side effects experienced can vary depending on the condition being treated.

Contraindications

The current FDA-approved labeling lists no contraindications for this medication.

Pregnancy and Breastfeeding

Reblozyl may cause fetal harm based on animal studies.

Females who can become pregnant should:

  • Have pregnancy testing before starting treatment
  • Use effective contraception during treatment
  • Continue effective contraception for at least 3 months after the last dose

The FDA labeling advises against breastfeeding during treatment and for 3 months after the last dose. This medication may also affect female fertility.

Access to Multiple Medications

Support Beyond Reblozyl

Do you need anemia medication assistance along with support for other specialty medications?

Prescription Hope routinely helps qualified patients access multiple medication assistance programs at the same time. Whether you need help with one medication or several, our dedicated team provides specialty medication support for a simple $70.00 per month, per medication.

Why Choose Prescription Hope for Medication Assistance

Patient-Focused Medication Support

For two decades, Prescription Hope’s dedicated patient advocate team has helped qualified patients access patient-centered support, prescription cost assistance, and affordable medication access. Our Florida-based medication access specialists provide Prescription Hope medication assistance, including Prescription Hope medication assistance and prescription support for eligible patients.

Simplified Access to Specialty Therapies

At Prescription Hope, our medication access services and specialty prescription assistance help qualified patients get the support they need to lower medication costs and gain peace of mind about prescription medication prices. This includes support for patients seeking luspatercept-aamt assistance and anemia treatment assistance.

Ongoing Prescription Assistance

Prescription Hope patient assistance goes beyond treatment support by providing long-term medication affordability support designed to help qualified patients stay on track with their prescriptions. Our dedicated team of patient advocates manages important details such as form and document updates, issue resolution, yearly renewals, program monitoring, and refill scheduling.

If you are looking for a simpler way to access affordable brand-name medications like Reblozyl, enroll with Prescription Hope today and let our team help guide you through the assistance process.

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!